cGxP.wire https://validator.w3.org/feed/docs/rss2.html Calidi Biotherapeutics Highlights CLD-401 Cancer Therapy Data Kirin and Blackmores Launch Cognizin® Cognitive Supplements Seegene Targets New Global PCR Standard for Reproductive Health CSL Reports Positive Phase 3b Results for Pediatric ANDEMBRY HoneyNaps Expands AI Clinical Trial Analytics as CRO Waters Strengthens Clinical Diagnostics with Xevo XR Innovation Veru Completes Enrollment in Phase 2b PLATEAU Obesity Trial BioMarin Partners n-Lorem on First ReNU Syndrome Therapy Ascletis Reports ASC37 Shows Superior Weight Loss in Obesity Study IDEAYA Biosciences Advances IDE892 in MTAP-Deleted Cancers Biohaven and Yale Secure Major Win in MODA Technology Dispute Bambusa Therapeutics Reports Positive Early Phase 1 Results for BBT001 in Atopic Dermatitis Alexion, AstraZeneca Rare Disease Shares Phase 3 Ultomiris Trial Results Kelun-Biotech Advances First Dual-Payload ADC into Clinical Trials AstraZeneca’s Sone-Ve Delivers Phase III Survival Breakthrough MapLight Therapeutics Announces Positive Phase 2 Schizophrenia Data CAMP4 Therapeutics Receives Australian Clearance for First-in-Human CMP-002 Trial Neumora Therapeutics Announces Positive NMRA-215 Toxicology Findings Nova Biomedical Expands Cell Line Development Platform VERAXA Biotech and OmniAb Collaborate on VXA-222 Bispecific ADC Otsuka’s SIMTRIYO® Becomes First Approved NDSRI for ADHD Yarrow Bioscience Completes VYNE Merger, Advances YB-101 into Phase 2 Trial ITM Launches Lumara Bio to Advance Radiopharmaceutical Oncology Pipeline Glaukos Completes Enrollment in PRESERFLO MicroShunt Pivotal Study Gossamer Bio Reacquires Global Rights to Seralutinib Kura Oncology Announces Positive Phase 1 Kidney Cancer Data Eli Lilly Reports Positive Phase 3 Retatrutide Results Harbour BioMed, Sinopharm Form Innovation R&D Consortium argenx SE Expands Immunology Pipeline with Forte Biosciences Deal AnHorn Medicines Advances AH-008 into Phase I Trial for CIPN Prevention AnX Robotica Unveils NaviCONNECT Cloud Platform for GI Diagnostics NewAmsterdam Pharma Wins CHMP Support for Ubeslo® and Evlarco® Zevra Therapeutics to Seek EU Re-Examination for Arimoclomol After CHMP Opinion Advita Ortho Reports First Clinical Use of Activit-E® Humeral Liners Kenvue’s Tylenol® Earns FDA Approval for OTC Naproxen Combination Par Health Launchs First FDA-Approved Generic Janumet® XR in U.S. Elephas Biosciences Expands elive™ Platform to Targeted Therapies Accord BioPharma Launches Two Denosumab Biosimilars Persica Pharmaceuticals Presents New PP353 Data Supporting Non-Opioid Chronic Low Back Pain Treatment Immutep Announces ESMO 2026 Presentation for EFTISARC-NEO Trial Alps Dx Launches Xpressor to Improve Oral Fluid Sample Quality Apertura Joins ARPA-H Program for Rare Gene Therapies SimBioSys, Ferrum Expand AI Breast Surgery Planning Momentis Surgical’s Anovo Becomes First Triple-Approach Robot MolecuLight Reports First Clinical Evidence for Fluorescence Imaging VELMENI Secures FDA 510(k) for AI-Powered 3D CBCT Imaging Minoryx Therapeutics Secures CHMP Backing for NEZGLYAL® in cALD FDA Moves to Revoke Two Petroleum-Based Food Color Additives Dassault Systèmes Powers Virtual Twin Factories with AI Agents Outlook Therapeutics Secures FDA Approval for LYTENAVA™